Will Palantir Crash?
AI and data analytics software major Palantir (NASDAQ:PLTR) has been…
Sell
34
SUPN Quote, Financials, Valuation and Earnings
Last price:
$32.73
Seasonality move
:
10.72%
Day range:
$31.80 - $33.15
52-week range:
$25.55 - $40.28
Dividend yield:
0%
P/E ratio:
29.25x
P/S ratio:
2.72x
P/B ratio:
1.76x
Volume:
1.2M
Avg. volume:
513.3K
1-year change:
24.93%
Market cap:
$1.8B
Revenue:
$661.8M
EPS (TTM):
$1.11
SUPN Analysts' Consensus Rating
The 5 analysts providing 12-month price projections for Supernus Pharmaceuticals shares anticipate an average target of $39.00, ranging from a low estimate of $36.00 to a high estimate of $45.00. This average target implies a growth of 19.5% compared to the current stock price of $32.47.
Consensus Price Target
$39.00
Highest Price Target
$45.00
Lowest Price Target
$36.00
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Analyst Ratings
| 6M Ago | 1M Ago | Current | |
|---|---|---|---|
| Buy | 2 | 2 | 2 |
| Hold | 2 | 3 | 3 |
| Sell | 0 | 0 | 0 |
| Consensus | Leans Bullish | Hold | Hold |
SUPN Recommendation Trends
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Target’s Dividend Worth Buying?
Retail giant Target (NYSE:TGT) has been through an extremely volatile…
Where Will AST SpaceMobile Be In 5 Years?
Ever tried to send a text from the Nevada desert…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.6T
P/E Ratio: 41x
Buy
60
Is NVDA Stock a Buy?
Market Cap: $3.5T
P/E Ratio: 49x
Sell
37
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Sell
49
RGC alert for Jun 17
Regencell Bioscience Holdings [RGC] is up 16.77% over the past day.
Buy
59
SYM alert for Jun 17
Symbotic [SYM] is down 2.77% over the past day.
Sell
43
TNXP alert for Jun 17
Tonix Pharmaceuticals Holding [TNXP] is down 5.3% over the past day.
